These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6762925)

  • 1. Is there a role for thymidine in cancer chemotherapy?
    Schornagel JH; Leyva A; Pinedo HM
    Cancer Treat Rev; 1982 Dec; 9(4):331-52. PubMed ID: 6762925
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of thymidine in biochemical modulation: a review.
    O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B
    Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of thymidine.
    Martin DS; Stolfi RL; Sawyer RC; Nayak R; Spiegelman S; Young CW; Woodcock T
    Cancer; 1980 Mar; 45(5 Suppl):1117-28. PubMed ID: 6986974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of 5-FU action by thymidine in murine and human tumors.
    Young CW; Woodcock TM; Martin DS
    Cancer Treat Rep; 1981; 65 Suppl 3():83-7. PubMed ID: 7346156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.
    Semon JH; Grindey GB
    Cancer Res; 1978 Sep; 38(9):2905-11. PubMed ID: 679199
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.
    Ellims PH
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):1-6. PubMed ID: 6186411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by thymidine of 5-fluorouracil's inhibition of thymidylate synthetase in human tumors.
    Wolberg WH
    Cancer Treat Rep; 1979; 63(11-12):1817-20. PubMed ID: 526916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical modulation: application of laboratory models to the clinic.
    Leyland-Jones B; O'Dwyer PJ
    Cancer Treat Rep; 1986 Jan; 70(1):219-29. PubMed ID: 3510736
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches to cancer chemotherapy with methotrexate.
    Frei E; Jaffe N; Tattersall MH; Pitman S; Parker L
    N Engl J Med; 1975 Apr; 292(16):846-51. PubMed ID: 1078714
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation.
    Woodcock TM; Martin DS; Damin LA; Kemeny NE; Young CW
    Cancer; 1980 Mar; 45(5 Suppl):1135-43. PubMed ID: 7357508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic modulation as a method in tumor chemotherapy].
    Tschiersch B
    Pharmazie; 1982 Jul; 37(7):475-8. PubMed ID: 6813882
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymidine rescue of high-dose methotrexate in humans.
    Howell SB; Ensminger WD; Krishan A; Frei E
    Cancer Res; 1978 Feb; 38(2):325-30. PubMed ID: 637906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T
    Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.
    Benz C; Choti M; Newcomer L; Cadman E
    Cancer Chemother Pharmacol; 1984; 12(2):104-10. PubMed ID: 6199130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
    Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
    Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the relationship of leukemic cell kinetics to chemotherapy.
    Killmann SA; Ernst P
    Bibl Haematol; 1973; 39():1037-45. PubMed ID: 4777986
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential administration of thymidine, 5-fluorouracil, and PALA. A phase I-II study.
    Chiuten DF; Miller A; Valdivieso M; Loo TL; Bedikian A; Bodey GP; Benvenuto JA; Freireich EJ
    Am J Clin Oncol; 1985 Aug; 8(4):332-5. PubMed ID: 4083263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.
    Spiegelman S; Nayak R; Sawyer R; Stolfi R; Martin D
    Cancer; 1980 Mar; 45(5 Suppl):1129-34. PubMed ID: 7357507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.